SCHEMBL7515044

SCHEMBL7515044

COc1ccc(C=CC2=CC(=O)OC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.48
ALDH1A1 P00352 3/20 0.48
HPGD P15428 2/20 0.48
TP53 P04637 2/20 0.48
MAPT P10636 2/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TRPA1 O75762 1/20 0.47
RELA Q04206 1/20 0.47
AHR P35869 2/20 0.46
CYP1A2 P05177 3/20 0.46
CYP1A1 P04798 3/20 0.46
CYP1B1 Q16678 3/20 0.46
ESR1 P03372 2/20 0.46
PTGS2 P35354 2/20 0.46
ABL1 P00519 1/20 0.46
TTR P02766 1/20 0.46
ABCB1 P08183 1/20 0.46
ALOX5 P09917 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7515036 1.00 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1HPGDTP53MAPT
SCHEMBL7518829 0.79 PTGS1 (0.39) ALDH1A1HPGDMAPTPTGS2TUBB4A
SCHEMBL7520340 0.79 MAOB (0.46) HSD17B10AHRCYP1A2NFE2L2RAB9A
SCHEMBL7518821 0.79 PTGS1 (0.39) ALDH1A1HPGDMAPTPTGS2TUBB4A
SCHEMBL7523379 0.78 MAOB (0.42) SMN1; SMN2ALDH1A1HPGDMAPTTRPA1
SCHEMBL7523377 0.78 MAOB (0.42) SMN1; SMN2ALDH1A1HPGDMAPTTRPA1
SCHEMBL7522363 0.76 ATM (0.51) SMN1; SMN2ALDH1A1HPGDMAPTHSD17B10
SCHEMBL7522354 0.76 ATM (0.51) SMN1; SMN2ALDH1A1HPGDMAPTHSD17B10
SCHEMBL4881152 0.73 RELA (0.81) SMN1; SMN2ALDH1A1HPGDTP53MAPT
SCHEMBL631998 0.73 RELA (0.81) SMN1; SMN2ALDH1A1HPGDTP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173420-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY Novuspharma S.p.A. (IT) 2002-01-23 EP disclosed
WO-2000053581-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY NOVUSPHARMA S.P.A. (IT) 2000-09-14 WO disclosed